How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Data Middle Market
- By Data Source Type: Electronic Health Records (EHR), Medical Imaging Data, Genomic Data, Claims and Billing Data, Patient-Generated Health Data
- By End User Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Health Insurance Payers, Medical Device Manufacturers, Clinical Research Organizations
- By Data Format: Structured Data, Unstructured Data, Semi-Structured Data, Time-Series Data, Imaging Data Formats (DICOM)
- By Data Usage Application: Clinical Decision Support, Population Health Management, Drug Development and Clinical Trials, Revenue Cycle Management, Predictive Analytics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Electronic Health Records (EHR) leads By Data Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Medical Data Middle Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Data Source Type 5
End User Industry 5
Data Format 5
Data Usage Application 5
Companies profiled
Cerner Corporation (now part of Oracle)
Epic Systems Corporation
McKesson Corporation
Allscripts Healthcare Solutions
Philips Healthcare
GE Healthcare
Siemens Healthineers
Optum (UnitedHealth Group)
MEDITECH
athenahealth (part of Veritas Capital)
Change Healthcare
IBM Watson Health
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cerner Corporation (now part of Oracle)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →McKesson Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Allscripts Healthcare Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Siemens Healthineers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Optum (UnitedHealth Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MEDITECH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →athenahealth (part of Veritas Capital)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Change Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →IBM Watson Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Oracle Health Sciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →CERNER (Oracle)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Health Catalyst
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$817.0M by 2033 · 3.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Electronic Health Records (EHR)61.6
- Medical Imaging Data12.0
- Genomic Data11.6
- Claims and Billing Data7.6
- Patient-Generated Health Data7.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$206.5M → $302.1M · 4.9%
Europe$143.9M → $185.6M · 3.2%
Asia Pacific$131.4M → $191.9M · 4.9%
Latin America$81.3M → $112.8M · 4.2%
Middle East and Africa$62.6M → $80.8M · 3.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.332026
3.352027
3.372028
3.372029
3.382030
3.412031
3.412032
3.422033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cerner Corporation (now part of Oracle)17.3
- Epic Systems Corporation20.4
- McKesson Corporation6.9
- Allscripts Healthcare Solutions5.4
- Philips Healthcare12.4
- GE Healthcare9.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Data Source Type31.4%
End User Industry23.9%
Data Format24.3%
Data Usage Application20.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.6
- Europe21.3
- Asia Pacific22.0
- Latin America12.9
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cerner Corporation (now part of Oracle) | 82 | 81 | 95 | 93 | 90 | 90 | 89 |
| Epic Systems Corporation | 75 | 87 | 88 | 68 | 70 | 91 | 80 |
| McKesson Corporation | 79 | 81 | 81 | 62 | 63 | 74 | 73 |
| Allscripts Healthcare Solutions | 81 | 60 | 73 | 81 | 82 | 67 | 74 |
| Philips Healthcare | 52 | 53 | 60 | 75 | 57 | 61 | 60 |
| GE Healthcare | 46 | 46 | 53 | 54 | 53 | 53 | 51 |
| Siemens Healthineers | 65 | 46 | 46 | 47 | 58 | 48 | 52 |
| Optum (UnitedHealth Group) | 44 | 39 | 40 | 48 | 51 | 49 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cerner Corporation (now part of Oracle)
- Epic Systems Corporation
- McKesson Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cerner Corporation (now part of Oracle) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Epic Systems Corporation | − | ◐ | ✓ | − | − | ✓ |
| McKesson Corporation | ◐ | ◐ | ✓ | − | ◐ | ✓ |
| Allscripts Healthcare Solutions | ✓ | ◐ | − | ◐ | ◐ | ✓ |
| Philips Healthcare | − | − | − | ◐ | ◐ | ◐ |
| GE Healthcare | − | − | − | ◐ | ◐ | ◐ |
| Siemens Healthineers | ◐ | ◐ | − | − | ◐ | − |
| Optum (UnitedHealth Group) | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cerner Corporation (now part of Oracle)89
2Epic Systems Corporation80
3Allscripts Healthcare Solutions74
4McKesson Corporation73
5Philips Healthcare60
6Siemens Healthineers52
7GE Healthcare51
8Optum (UnitedHealth Group)45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Cerner Corporation (now part of Oracle)Epic Systems Corporation
Challenger2
Strong scale, closing on the leaders.
McKesson CorporationAllscripts Healthcare Solutions
Contender1
Focused players with pockets of strength.
Philips Healthcare
Niche3
Specialists in a single segment or region.
GE HealthcareSiemens HealthineersOptum (UnitedHealth Group)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Data Source Type in North America, then scale across Medical Data Middle Market — a $351M beachhead inside a $5.26B market.
Beachhead (SOM)$351Mobtainable near-term
Serviceable (SAM)$2.09Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Electronic Health Records (EHR)
Best fit — highest urgency & budget in Data Source Type.
Economic buyer78 fit
Medical Imaging Data
Strong fit — clear ROI and a fast path to value.
End user70 fit
Genomic Data
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Data Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User Industry & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Data Format
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve22%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Data Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Data Middle Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified26%
Evaluation13%
Closed-won7%
$21.9KCAC
$83KLTV
3.8:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Data Middle Market is a durable-growth opportunity — $1.15B by 2033, compounding at 10.0%.
TAM · 2025$539Mtoday
TAM · 2033$1.15Bforecast
CAGR10.0%2027–2033
Cumulative$7.32Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.15BTotal addressable market
SAM$425MServiceable available market
SOM$73MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.0% CAGR
Demand compounds through 2033, outpacing GDP across Data Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Data Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.15BLarge & growingTAM by 2033 at 10.0% CAGR
$425MServiceable nowreachable with today’s model
$73MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$901MBear6.5% CAGR
$1.15BBase10.0% CAGR
$1.48BBull13.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User Industry optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Data Middle Market — a $7.69B market by 2033. Plan: grow share from 7.0% to 14.9%.
Market size · 2033$7.69Btotal addressable
Market CAGR6.7%2027–2033
Target share14.9%from 7.0% today
Revenue ambition$1.15Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.0% | 14.9% | On track |
| Revenue | $491M | $1.15B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 31.0% | 44.2% | Ahead |
| Customer retention | 87.4% | 94.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Data Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User Industry capability
A defensible second engine — invest in End User Industry to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Data Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User Industry
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $171M capacity & capability investment
- Greenlight bolt-on M&A in End User Industry
- Authorise North America expansion plan
- Fund R&D program for Data Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Data Middle Market conversation — a $2.54B market you can size, segment and defend in minutes.
Market size · 2033$2.54Btotal opportunity
Growth9.6%CAGR to 2033
Addressable buyers1,755+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Data Source Type
Goal Grow share in Data Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Cerner Corporation (now part of Oracle)Epic Systems CorporationMcKesson CorporationAllscripts Healthcare SolutionsPhilips HealthcareGE HealthcareSiemens HealthineersOptum (UnitedHealth Group)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Data Middle Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Data Middle Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Daily Work Clothing Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportMedical Cylindrical Type Lithium Manganese Dioxide Battery Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMedical Cylindrical Primary Lithium Batteries Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMedical Cylindrical Collection Tube Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportMedical Curtain Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportMedical CT Overlays Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportMedical CT High Pressure Injection System Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportMedical CT Film Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportMedical Cryo Tubes Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMedical Cryotherapy Rooms Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportMedical Cryolipolysis Machines Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportMedical Cryogenic Storage Equipment Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.